Johnson and Johnson
Cap Gemini Ernst and Young
Prior to Churchill, Sharlene was Head of Global Market Access for the oncology portfolio at GSK/Novartis. The portfolio spanned solid tumors, hematology and supportive care as well as early-stage development products for which Sharlene oversaw development of product value propositions and global market access and pricing strategy. Sharlene led global and US marketing teams for multiple products, including heritage cytotoxics, partnerships and the US launch for renal cell cancer. Sharlene has also worked in pharmaceutical management consulting managing global business process improvement efforts in healthcare, R&D and commercial, with experience in clinical development and medical affairs studies, trial execution and NDA submissions.